At Home Monitoring for Patients With Covid19

Sponsor
University Health Network, Toronto (Other)
Overall Status
Recruiting
CT.gov ID
NCT04453774
Collaborator
Sunnybrook Health Sciences Centre (Other), University of Toronto (Other)
1,000
2
1
28.9
500
17.3

Study Details

Study Description

Brief Summary

The vast majority of individuals with Covid19 have mild illness that can be managed in the outpatient setting. A small but significant number of these people will deteriorate and require hospitalization. Symptoms are a poor - and possibly late - indicator for deterioration. While people who have died, and/or been cared for in the ICU or hospital have been well characterized, there remains a dearth of information about the clinical course of people in the outpatient setting. Most notably, it is not known when to escalate to hospital care. The consequence of non-escalation when needed is significant patient morbidity and mortality, of escalation when not needed is unnecessarily overwhelmed hospitals. Technologies for clinical management and early diagnostics for severe Covid19 infection will address this challenge.

The research goal of this study is to use real-time remote patient monitoring to detect which patients with Covid19 are at risk of deterioration to bring to hospital, while at the same ensuring the worried will receive reassurance so they stay at home. The clinical goal is to help clinicians provide excellent care using ubiquitous mobile phones.

Condition or Disease Intervention/Treatment Phase
  • Device: Covidfree@home
N/A

Detailed Description

People with COVID infection recovering at home or in long-term care are at high risk of hospitalization and death, a reservoir of the disease, and the source of any second wave. Three important gaps still besiege their well-being and, consequently, the well-being of all of us. First, we cannot yet accurately predict the approximately 10% who deteriorate and need hospitalization. Deterioration happens quick and without warning. Delayed detection of deterioration worsens patient outcomes. Second, COVID patients feel terrified and alone. This leads them to come to EDs when not indicated, to have poor mental health and to risk violating physical distancing rules. Third, the health of people with COVID cannot be improved without having a means of studying and understanding what they are going through. None of these gaps are being filled by public health.

It is imperative that Ontario have an effective and safe outpatient care and research strategy for people with COVID isolated at home and in long term care to survive this COVID pandemic.

The investigators are building a mobile smartwatch/smartphone application to create a scalable safe virtual system that meets the care needs of COVID patients at home and in long term care (including reassurance when they are doing well), that uses continuous symptom, heart rate, respiratory rate, cough and other monitoring to predict who needs to go to hospital in real time and that provides a research platform to learn how to further improve and preserve their health.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Covidfree@Home: At Home Monitoring Using Mobile Devices for Patients With Covid19
Actual Study Start Date :
Nov 1, 2020
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Covi19 patients receiving intervention

We will collect self-reported symptoms via a questionnaire, temperature and oxygen saturation will be entered by the patient and passive near continuous sensing of heart rate, audio for cough detection, respiratory rate, cough and physical activity from a smart watch. The smart watch then transmits this sensor data to the paired smartphone.

Device: Covidfree@home
Mobile phone, Covidfree@home app, thermometer, pulse oximeter, smart watch

Outcome Measures

Primary Outcome Measures

  1. Number of participants with an unplanned hospital admissions [30 days]

    Number of participants with an unplanned emergency department visits leading to hospital admission

  2. Number of participants with planned hospital admissions that are found to be necessary [30 days]

    Number of participants with planned hospital admissions that are found to be necessary

Secondary Outcome Measures

  1. Number of participants with an emergency department visits not resulting in hospital admission [30 days]

    Number of participants with an emergency department visit not resulting in a hospital admission

  2. Number of planned hospital admissions which are found to be unnecessary [30 days]

    Number of planned hospital admissions which are found to be unnecessary

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  • Patients who tested positive for Covid19

  • Patients experiencing symptoms of Covid19 and have been deemed to likely have Covid19

Exclusion Criteria

  • Does not speak English

  • Unable to use a mobile smartphone and smart watch

  • Unable to complete questionnaires on own

  • Significant comorbid condition that would confound symptoms and sensor readings

  • Deemed palliative with goals of care being comfort measures only

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sunnybrook Health Sciences Centre Toronto Ontario Canada M4N3M5
2 University Health Network Toronto Ontario Canada M5G 2Cr

Sponsors and Collaborators

  • University Health Network, Toronto
  • Sunnybrook Health Sciences Centre
  • University of Toronto

Investigators

  • Principal Investigator: Robert Wu, University Health Network, Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Robert Wu, General Internal Medicine Site Director, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT04453774
Other Study ID Numbers:
  • 3185
First Posted:
Jul 1, 2020
Last Update Posted:
May 24, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Robert Wu, General Internal Medicine Site Director, University Health Network, Toronto
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 24, 2021